Annual FCF
-$6.64 M
+$5.65 M+45.98%
30 September 2023
Summary:
Edesa Biotech annual free cash flow is currently -$6.64 million, with the most recent change of +$5.65 million (+45.98%) on 30 September 2023. During the last 3 years, it has risen by +$7.03 million (+51.46%). EDSA annual FCF is now -17503.45% below its all-time high of -$37.70 thousand, reached on 30 April 2009.EDSA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$856.50 K
+$803.70 K+48.41%
30 June 2024
Summary:
Edesa Biotech quarterly free cash flow is currently -$856.50 thousand, with the most recent change of +$803.70 thousand (+48.41%) on 30 June 2024. Over the past year, it has increased by +$611.50 thousand (+41.66%). EDSA quarterly FCF is now -208.54% below its all-time high of -$277.60 thousand, reached on 30 November 2010.EDSA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$5.39 M
+$948.70 K+14.96%
30 June 2024
Summary:
Edesa Biotech TTM free cash flow is currently -$5.39 million, with the most recent change of +$948.70 thousand (+14.96%) on 30 June 2024. Over the past year, it has increased by +$1.25 million (+18.76%). EDSA TTM FCF is now -1842.07% below its all-time high of -$277.60 thousand, reached on 30 November 2010.EDSA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDSA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +41.7% | +18.8% |
| 3 y3 years | +51.5% | -142.0% | +60.6% |
| 5 y5 years | -36.7% | - | - |
EDSA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.5% | -142.0% | +84.8% | at high | +61.1% |
| 5 y | 5 years | -36.7% | +51.5% | -142.0% | +88.1% | -174.9% | +64.0% |
| alltime | all time | <-9999.0% | +51.5% | -208.5% | +88.1% | -1842.1% | +64.0% |
Edesa Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$856.50 K(-48.4%) | -$5.39 M(-15.0%) |
| Mar 2024 | - | -$1.66 M(+18.0%) | -$6.34 M(+1.4%) |
| Dec 2023 | - | -$1.41 M(-4.2%) | -$6.25 M(-5.8%) |
| Sept 2023 | -$6.64 M(-46.0%) | -$1.47 M(-18.7%) | -$6.64 M(-38.5%) |
| June 2023 | - | -$1.81 M(+14.8%) | -$10.80 M(-10.2%) |
| Mar 2023 | - | -$1.57 M(-12.2%) | -$12.02 M(+10.6%) |
| Dec 2022 | - | -$1.79 M(-68.2%) | -$10.87 M(-11.6%) |
| Sept 2022 | -$12.29 M(-10.1%) | -$5.63 M(+85.9%) | -$12.29 M(+75.2%) |
| June 2022 | - | -$3.03 M(+624.6%) | -$7.01 M(-1.3%) |
| Mar 2022 | - | -$417.90 K(-87.0%) | -$7.11 M(-48.8%) |
| Dec 2021 | - | -$3.21 M(+807.3%) | -$13.87 M(+1.5%) |
| Sept 2021 | -$13.67 M(+172.3%) | -$353.90 K(-88.7%) | -$13.67 M(-8.8%) |
| June 2021 | - | -$3.12 M(-56.5%) | -$14.99 M(+13.1%) |
| Mar 2021 | - | -$7.18 M(+138.5%) | -$13.25 M(+83.0%) |
| Dec 2020 | - | -$3.01 M(+79.6%) | -$7.24 M(+44.3%) |
| Sept 2020 | -$5.02 M(+3.4%) | -$1.68 M(+21.3%) | -$5.02 M(+50.2%) |
| June 2020 | - | -$1.38 M(+18.0%) | -$3.34 M(+70.5%) |
| Mar 2020 | - | -$1.17 M(+48.3%) | -$1.96 M(-5.6%) |
| Dec 2019 | - | -$789.70 K(-38.6%) | -$2.08 M(-57.3%) |
| Sept 2019 | -$4.85 M(-2.9%) | - | - |
| Mar 2019 | - | -$1.29 M(-2.1%) | -$4.86 M(-5.3%) |
| Dec 2018 | - | -$1.31 M(+32.4%) | -$5.13 M(+2.7%) |
| Sept 2018 | -$5.00 M(-0.1%) | -$992.60 K(-21.7%) | -$5.00 M(-4.3%) |
| June 2018 | - | -$1.27 M(-18.8%) | -$5.23 M(+5.1%) |
| Mar 2018 | - | -$1.56 M(+32.3%) | -$4.97 M(+5.1%) |
| Dec 2017 | - | -$1.18 M(-3.3%) | -$4.73 M(-5.4%) |
| Sept 2017 | -$5.00 M | -$1.22 M(+20.2%) | -$5.00 M(-1.6%) |
| June 2017 | - | -$1.01 M(-23.0%) | -$5.08 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$1.32 M(-9.0%) | -$5.17 M(+3.1%) |
| Dec 2016 | - | -$1.45 M(+11.6%) | -$5.01 M(+2.0%) |
| Sept 2016 | -$4.91 M(+4.7%) | -$1.30 M(+18.3%) | -$4.91 M(+6.8%) |
| June 2016 | - | -$1.10 M(-5.4%) | -$4.60 M(+0.8%) |
| Mar 2016 | - | -$1.16 M(-14.0%) | -$4.56 M(-3.3%) |
| Dec 2015 | - | -$1.35 M(+36.8%) | -$4.71 M(+0.5%) |
| Sept 2015 | -$4.69 M(+1411.0%) | -$986.70 K(-7.0%) | -$4.69 M(+3.8%) |
| June 2015 | - | -$1.06 M(-19.3%) | -$4.52 M(-0.2%) |
| Mar 2015 | - | -$1.31 M(-0.7%) | -$4.52 M(-3.1%) |
| Dec 2014 | - | -$1.32 M(+62.2%) | -$4.67 M(+2.7%) |
| Sept 2014 | -$310.20 K(-93.2%) | - | - |
| Aug 2014 | -$4.55 M(+62.0%) | -$816.60 K(-23.6%) | -$4.55 M(+5.8%) |
| May 2014 | - | -$1.07 M(-26.8%) | -$4.29 M(+8.7%) |
| Feb 2014 | - | -$1.46 M(+21.7%) | -$3.95 M(+20.5%) |
| Nov 2013 | - | -$1.20 M(+112.1%) | -$3.28 M(+16.9%) |
| Aug 2013 | -$2.81 M(-30.3%) | -$565.90 K(-22.1%) | -$2.81 M(-12.8%) |
| May 2013 | - | -$726.20 K(-7.9%) | -$3.22 M(-8.3%) |
| Feb 2013 | - | -$788.80 K(+8.9%) | -$3.51 M(-8.9%) |
| Nov 2012 | - | -$724.50 K(-25.8%) | -$3.85 M(-4.3%) |
| Aug 2012 | -$4.03 M(+37.5%) | -$976.70 K(-4.2%) | -$4.03 M(+0.4%) |
| May 2012 | - | -$1.02 M(-9.9%) | -$4.01 M(+0.4%) |
| Feb 2012 | - | -$1.13 M(+25.8%) | -$3.99 M(+12.5%) |
| Nov 2011 | - | -$899.40 K(-6.5%) | -$3.55 M(+21.2%) |
| Aug 2011 | -$2.93 M(+256.5%) | -$961.60 K(-4.0%) | -$2.93 M(+48.9%) |
| May 2011 | - | -$1.00 M(+45.7%) | -$1.97 M(+103.8%) |
| Feb 2011 | - | -$687.00 K(+147.5%) | -$964.60 K(+247.5%) |
| Nov 2010 | - | -$277.60 K | -$277.60 K |
| Aug 2010 | -$821.10 K(+2078.0%) | - | - |
| Apr 2009 | -$37.70 K | - | - |
FAQ
- What is Edesa Biotech annual free cash flow?
- What is the all time high annual FCF for Edesa Biotech?
- What is Edesa Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Edesa Biotech?
- What is Edesa Biotech quarterly FCF year-on-year change?
- What is Edesa Biotech TTM free cash flow?
- What is the all time high TTM FCF for Edesa Biotech?
- What is Edesa Biotech TTM FCF year-on-year change?
What is Edesa Biotech annual free cash flow?
The current annual FCF of EDSA is -$6.64 M
What is the all time high annual FCF for Edesa Biotech?
Edesa Biotech all-time high annual free cash flow is -$37.70 K
What is Edesa Biotech quarterly free cash flow?
The current quarterly FCF of EDSA is -$856.50 K
What is the all time high quarterly FCF for Edesa Biotech?
Edesa Biotech all-time high quarterly free cash flow is -$277.60 K
What is Edesa Biotech quarterly FCF year-on-year change?
Over the past year, EDSA quarterly free cash flow has changed by +$611.50 K (+41.66%)
What is Edesa Biotech TTM free cash flow?
The current TTM FCF of EDSA is -$5.39 M
What is the all time high TTM FCF for Edesa Biotech?
Edesa Biotech all-time high TTM free cash flow is -$277.60 K
What is Edesa Biotech TTM FCF year-on-year change?
Over the past year, EDSA TTM free cash flow has changed by +$1.25 M (+18.76%)